BMI View: Growth in Lebanon's pharmaceutical market will be heavily driven by the sales of high-value
prescription medicines thanks to an aging population, relatively high per capita spending and rising disease
burden. Furthermore, the Health Ministry's recent move to ..."
BMI View: We believe the Lebanese government's focus on improving healthcare access and quality across
the country coupled with a rising disease burden and relatively high per capita spending will drive the
demand of high-value prescription medicines. The Ministry of ..."
BMI View: We hold a cautiously optimistic outlook for Lebanon's pharmaceutical market over the coming
years. The government's focus on improving healthcare access across the country coupled with a rising
disease burden and relatively high per capita spending will driv ..."
BMI View: We hold a bullish outlook for Lebanon's pharmaceutical market, the government's commitment
to improving healthcare access coupled with a rising non-communicable disease burden will be a key
driving factor for growth over the long-term. However, economic stag ..."
BMI View: The Lebanese Health Ministry's pledge to invest in improving the condition of poorly equipped
state-owned hospitals across the country as well as increasing its coverage of patient bills at such hospitals
reaffirms our view that the government remains commit ..."
BMI View: Lebanon's drug pricing legislation will keep medicine prices among the lowest in the Middle
East region. In addition to this, the government's commitment to achieving universal access to healthcare
will drive growth in the pharmaceutical market. Generic drug ..."
BMI View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seeking
treatment in the country has sharply risen. Continued political instability will negatively impact government
policy regarding healthcare and will in turn put the p ..."
BMI View: The influx of Syrian refugees into Lebanon is putting a strain on the healthcare system, which is
unable to meet the additional demand for treatment. Elevated political instability is putting the
pharmaceutical sector at risk in terms of government policy relating to ..."
BMI View: Lebanon benefits from a sizeable healthcare sector where the costs of health services and drug
prices are generally high. The private sector accounts for about 90% of Lebanon's hospitals and
pharmacies, driving the prescription of high-value pharmaceuticals. ..."
BMI View: This quarter has seen Lebanon become more attractive to innovative product launches due to
more favourable country demographics. However, we highlight that access to medicines will become
increasingly difficult due to ongoing sectarian tensions, political in ..."